Early Post-Prostatectomy PSA Tests Can Determine Recurrence Risk

Early Post-Prostatectomy PSA Tests Can Determine Recurrence Risk
shutterstock_216274144A recent study from a team of investigators from the Czech Republic suggests prompt monitoring of prostate specific antigen levels (PSA) in patients after a radical prostatectomy (RP) may be a reliable measure to determine the necessity of post-surgical radiotherapy to prevent disease recurrence. Lead investigator Dr. Stepan Vesely from the Charles University 2nd Faculty of Medicine University Hospital in Prague, and his colleagues published a report of their findings in the journal BMC Urology. The study involved the participation of 116 patients known to have positive surgical margins (PSMs) after undergoing RP for localized prostate cancer, and had not received any form of radio- or hormonal therapy. At 14 days post-operation, the participants' PSA levels were evaluated using an ultrasensitive assay, which was repeated on day 30, 60, 90, and 180, followed by more distanced monitoring every 3 months. According to their findings, 47 percent of patients were noted to have biochemical failure (BCR), which is defined as having a PSA level of at
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *